biohaven: "rimegepant pivotal phase 3 trial results -- conference call."
.white house to ban federal funds for clinics that discuss abortion with patients : the two-way
.
following close on aimovig's heels are three other drugs that target cgrp: fremanezumab, galcanezumab, and eptinezumab (which is given by iv). . .